Diagnostics in pulmonary hypertension

Journal of Physiology and Pharmacology

Volumn 58, Issue SUPPL. 5, 2007, Pages 591-602

  Schannwell, C M ^a   Steiner, S ^a   Strauer, B E ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Exercise capacity; Pulmonary artery hypertension; Six minute walk test; Tei Index

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

AIR CONDITIONING; ARTICLE; BLOOD GAS ANALYSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; DYSPNEA; ELECTROCARDIOGRAPHY; EXERCISE; FATIGUE; HEART CATHETERIZATION; HEART FAILURE; HEART OUTPUT; HEART VENTRICLE FUNCTION; HEMODYNAMICS; HUMAN; HYPOXEMIA; LUNG ARTERY PRESSURE; PROGNOSIS; PULMONARY HYPERTENSION; SYNCOPE; THORAX RADIOGRAPHY; VASCULAR RESISTANCE; WORLD HEALTH ORGANIZATION;

HUMANS; HYPERTENSION, PULMONARY; MONITORING, PHYSIOLOGIC; PROGNOSIS; TERMINOLOGY AS TOPIC;

EID: 40449121143     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. MacNee W. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Part One. Am J Respir Crit Care Med 1994; 150:833-852.
2. Hatano S, Strasser T. World Health organization 1975 primary pulmonary hypertension. Geneva. WHO; 1975.
3. Rubin LJ. Primary pulmonary hypertension. N Engl J Med 1997; 336:111-117.
4. Galie N, Torbicki A, Barst R et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The task force on diagnosis and treatment of pulmonary arterial hypertension of the European society of cardiology. Eur Heart 2004; 25:2243-2278.
5. Fox DJ, Khattar RS. Pulmonary arterial hypertension: classification, diagnosis and contemporary management. Postgrad Med J 2006; 82:717-722.
6. Simonneau G, Galie N, Rubin L et al. Clinical classification of pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43:S5-S12.
7. Rich S, Dantzker DR, Ayres SM et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med 1987; 107:216-223.
8. Gurubhavatula I, Palevsky HI. Pulmonary hypertension in systemic autoimmune disease. Rheum Dis Clin North Am 1997; 23:365-394.
9. Nauser TD, Stites St. Diagnosis and treatment of pulmonary hypertension. Am Fam Physician 2001; 63:1789-1798.
10. Palevsky HI, Fishman AP. Chronic cor pulmonale. Etiolology and management. JAMA 1990; 263:2347-2353.
11. Wood P. Primary pulmonary hypertension, with special references to the vasoconstrictive factor. Br Heart J 1958; 20:557-565.
12. Farber HW, Loscalzo J. Mechanisms of disease. N Engl J Med 2004; 351:1655-1665.
13. Humbert M, Morrel N, Archer S et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43:S13-S24.
14. Ahearn GS, Tapson VF, Rebeiz A et al. Electrocardiography to define clinical status in primary pulmonary hypertension and pulmonary arterial hypertension secondary to collagen vascular disease. Chest 2002; 122:524-527.
15. Widimsky J. Noninvasive diagnosis of pulmomary hypertension in chronic lung disease. Prog Respir Res 1985; 20:69-75.
16. Tei C, Dujardin KS, Hodge DO, Bailey KR, McGoon MD, Tajik AJ, Seward SB. Doppler echocardiographic index for assessment of global right ventricular function. J Am Soc Echocardiogr 1996; 9:838-847.
17. Leuchte HH, Holzapfel M, Baumgartner RA et al. Clinical significance of brain natriuretic peptide in primary pulmonary hypertension. J Am Coll Cardiol 2004; 43:764-770.
18. Leuchte HH, Baumgartner RA, Nounou ME et. Brain natriuretic peptide is a prognostic parameter in chronic lung disease. Am J Respir Crit Care Med 2006; 173:744-750.
19. Gan CT, McCann GP, Marcus JT et al. NT-proBNP reflects right ventricular structure and function in pulmonary hypertension. Eur Respir J 2006; 28:1190-1194.
20. Huffman M, McLaughlin V. Evaluation and diagnosis of pulmonary arterial hypertension. US Cardiovascular Disease, 2006.
21. Budev MM, Arroliga AC, Jennings CA. Diagnosis and evaluation of pulmonary hypertension. Cleve Clin J Med 2003; 70:S9-S17.
22. Frank H, Globits S, Glogar D et al. Detection and quantification of pulmonary artery hypertension with MR imaging: results in 23 patients. Am J Roentgenol 1993; 161:27-31.
23. Paciocco G, Martinez FJ, Bossone E et al. Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension. Eur Respir J 2001; 17:647-652.
24. Miyamoto S, Nagaya N, Satoh T et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 2000; 161:487-492.
25. Wensel R, Opitz CF, Anker SD et al. Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing. Circulation 2002; 106:319-324.
26. Ghio S, Gavazzi A, Campana C et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic failure. J Am Coll Cardiol 2001; 37:183-188.